La Jolla California event

14th Annual Outsourcing in Clinical Trials Southern California

  • Start Date:

    15 Sep 2026

  • End Date:

    16 Sep 2026

  • Location:

    La Jolla, CA

  • Region:

    North America

  • Booth #:

    52

Join Thermo Fisher Scientific at OCT Southern California

Join Thermo Fisher Scientific at OCT Southern California to connect with our experts and discover how our integrated clinical development solutions help sponsors accelerate development with greater confidence. From early development through commercialization, we bring together scientific expertise, operational excellence and flexible partnership models designed to help sponsors navigate complexity, reduce risk and deliver results.

Whether you’re exploring new outsourcing strategies, optimizing an existing partnership or preparing for your next clinical program, stop by Booth #52 to meet our team and discuss how we can help advance your goals.

Featured speaking session

The Partnership Illusion: Exposing the silos that quietly undermine clinical execution

Tuesday, September 15 | 2:30 p.m. | Stream A

Sponsors and CROs strive for effective partnerships, yet even the most experienced organizations still find themselves reacting to issues that should have been identified much earlier. Why?

Join us for this thought-provoking session as we uncover the hidden operational silos that develop within sponsors, within CROs and across the partnership itself. Drawing on experience across clinical operations, project management, rare disease oversight, strategic solutions and biotech leadership, this session challenges the notion that outsourcing models alone determine success. Whether FSP, full service, milestone-based, outcome-based or hybrid, no delivery model can compensate for limited visibility, delayed risk identification, unclear accountability or fragmented decision making.

Attendees will leave with a new perspective on what truly drives high performing sponsor-CRO partnerships and practical strategies to identify risks earlier, strengthen accountability and improve clinical execution.

Key takeaways

  • Identify the hidden silos that create blind spots across sponsor-CRO partnerships.
  • Recognize the early warning signs of partnership breakdown before timelines and quality are impacted.
  • Learn practical approaches to improve visibility, accountability and cross-functional decision making.
  • Strengthen governance practices that enable more predictable clinical outcomes.

Meet our speaker

Terri Frisbie Myers - Vice President and Global Head of Biotech Operations

Terri Frisbie Myers 
Vice President and Global Head of Biotech Operations